Creating Healthy Mice from Gene-Corrected Stem Cells
Author Information
Author(s): Wu Guangming, Liu Na, Rittelmeyer Ina, Sharma Amar Deep, Sgodda Malte, Zaehres Holm, Bleidißel Martina, Greber Boris, Gentile Luca, Han Dong Wook, Rudolph Cornelia, Steinemann Doris, Schambach Axel, Ott Michael, Schöler Hans R., Cantz Tobias
Primary Institution: Max-Planck-Institute for Molecular Biomedicine, Münster, Germany
Hypothesis
Can gene-corrected induced pluripotent stem cells (iPS cells) be used to generate viable mice that exhibit normal liver function?
Conclusion
The study successfully generated healthy mice from gene-corrected iPS cells, demonstrating the potential of this approach for treating genetic diseases.
Supporting Evidence
- The gene correction was validated functionally by the long-term survival of FAH-positive cells in the mice.
- High efficiency of full-term development of up to 63.3% was achieved using gene-corrected iPS cells.
- Both liver-specific and strong viral promoters successfully rescued the FAH-deficiency phenotypes in the derived mice.
Takeaway
Scientists made sick mice healthy by fixing their genes in special cells and then using those cells to create new mice.
Methodology
The researchers used fibroblast-derived iPS cells from a mouse model of tyrosinemia, corrected the genes using a lentiviral vector, and then used tetraploid embryo complementation to generate healthy mice.
Potential Biases
Potential bias in the selection of iPS cell lines based on their developmental potential.
Limitations
The study did not explore the long-term effects of gene correction on all cell types or the potential for tumor formation.
Participant Demographics
Mice used in the study were genetically modified FAH−/− mice.
Statistical Information
P-Value
0.001
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website